The central target used in this analysis is $1.60 , a level roughly 37% above the latest verified price of about $1.17. This is not an analyst price target: FOXX has no credible sell-side price targets. It was established as a fallback based on public technical discussion of a recovery toward the stock's early-November consolidation zone.
The central price objective of $4.00 used here is the average of the small number of published analyst targets that sit above the current share price; it is not a robust Wall Street consensus. GreenPower Motor Company Inc. ( GP ) closed at $2.62 on November 17, 2026, meaning the stock would need to rise roughly 53% to reach $4.00.
The $2.75 target is not an analyst consensus . It is the published price objective of the single firm currently covering the stock, Alliance Global Partners, and is used here because there are too few analysts to form a meaningful average. At roughly $0.69, reaching $2.75 would require a gain of about 300%, a very large move.
The central $10.50 target is the arithmetic mean of the two most recent verifiable analyst price targets: an $8.50 Hold and a $12.50 Buy. It is not an official published consensus. With shares at $5.52, reaching $10.50 would require a roughly 90% advance, a very large move for a micro-cap manufacturer now posting losses.
The central price target of $2.50 is not an analyst-derived figure. Because no credible Wall Street price targets exist for MDBH, this target is drawn from public discussion—specifically an independent bull-case intrinsic-value estimate of roughly $2.53 per share. The target represents a move of roughly 71% from the latest verified price near $1.46, a very large move for any equity and especially for a thinly traded micro-cap.
The central price target discussed in this article is $15 , roughly 25% above the roughly $12 level where shares have recently traded. This is not an analyst consensus . With no credible analyst price targets available, the $15 figure is a technical and valuation milestone drawn from public discussion, not a published Wall Street target.
The central target discussed here is $1.50 , a psychological and technical price level roughly 28% above the latest verified close near $1.17, rather than an analyst-derived figure. EnerSyn Global Inc. (ESYN) currently has no credible published analyst price targets; the $1.50 objective is based on public technical discussion, not an analyst consensus.
Third quarter 2026 revenue declined 19% year over year to $10.2 million , well below consensus estimates of roughly $12.6 million. GAAP (generally accepted accounting principles) net loss was $1.4 million, or $0.08 per share , a wider loss than the approximately $0.04 per share analysts had projected.
The $8 central target is the arithmetic mean of five verified analyst price targets, rounded from roughly $8.20. Shares recently traded near $0.32, so the target implies upside of roughly 2,400% — a very large move that is not a near-term expectation.
Werewolf Therapeutics (HOWL) reported a third-quarter 2026 net loss of $9.9 million, narrowing from $16.4 million in the same period a year earlier. Net loss per share was $0.20, beating the consensus estimate of a $0.22 loss per share.
The central price target of $4.50 is the arithmetic mean of two verified analyst targets, a low of $4.00 and a high of $5.00, both set on June 8, 2026. The latest verified market price is about $0.55, meaning the stock would need to rise roughly 720% to reach the $4.50 target — a very large move.
ZenaTech (ZENA) is expected to report third-quarter 2026 (Q3 2026) results in mid-November 2026, following preliminary revenue guidance that points to a sharp sequential jump. Consensus estimates call for a net loss of roughly $0.18 per share on revenue of approximately $9.12 million , according to available analyst data.
The $13 figure cited for Northern Technologies International Corporation (NTIC) is a single published analyst price target from Northland Securities (analyst Gus Richard), not a broad Wall Street consensus. With shares trading near $7.60, reaching $13 would require an advance of roughly 71% — a very large move for this roughly $71 million micro-cap specialty-chemicals maker.
Vertical Aerospace (EVTL) is expected to report its fiscal third-quarter 2026 results in early-to-mid November 2026, with consensus estimates pointing to a loss of roughly $0.29 per share . As a pre-revenue electric aircraft developer, the company's top-line will remain minimal, shifting investor attention toward cash balances, operating cash outflow, and funding rather than sales growth.
The $20 central target is the single verified, attributable analyst price target on the stock, initiated by Jones Trading with a Buy rating in late September 2026 — it is not a multi-analyst consensus. With shares trading near $7 (about $6.98 at the most recent close), reaching $20 would require roughly a 185% advance, a very large move for any security.
The $5.90 central target is the arithmetic mean of two current analyst price targets — $6.75 from H.C. Wainwright and $5.00 from Maxim Group — giving a range of roughly $5.00 to $6.75. With shares trading near $1.53, reaching $5.90 would require a gain of roughly 285%, a very large move for any single research horizon.
Northern Technologies International Corporation (NASDAQ: NTIC) is scheduled to report its fiscal 2026 fourth-quarter results on Thursday, November 19, 2026, before the market opens . Wall Street consensus points to earnings per share (EPS) of roughly $0.06 on revenue near $25.2 million for the quarter ended August 31, 2026.
The central $4 price target is the arithmetic mean of five verified analyst price targets (about $3.90, rounded to $4), spanning a wide range of roughly $2 to $5. With the shares trading near $1.35, reaching $4 would require a gain of about 195% — a very large move that implies the stock must nearly triple.
Endava has delayed its fiscal fourth-quarter and full-year 2026 results, originally targeted for release by early November 2026, drawing added investor scrutiny. Company guidance calls for fiscal Q4 2026 revenue of £181 million to £185 million and adjusted diluted earnings per share (EPS) of 9p to 13p.
The central target used here is $16.25, the arithmetic mean of a small set of current analyst price targets that cluster in a wide range of roughly $15 to $19. The stock recently traded near $7 (closing around $7.39 in mid-November 2026), meaning the central target implies a move of roughly 120%, a very large required gain.
Previous
1 of 1792
Next